Man Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-26,302
| Closed | -$629K | – | 2404 |
|
|
2025
Q2 | $629K | Sell |
26,302
-22,333
| -46% | -$563K | ﹤0.01% | 1760 |
|
|
2025
Q1 | $1.21M | Buy |
+48,635
| New | +$1.16M | ﹤0.01% | 1532 |
|
|
2024
Q4 | – | Sell |
-69,031
| Closed | -$1.04M | – | 2143 |
|
|
2024
Q3 | $1.04M | Sell |
69,031
-21,575
| -24% | -$369K | ﹤0.01% | 1489 |
|
|
2024
Q2 | $2.59M | Buy |
90,606
+37,821
| +72% | +$1.08M | 0.01% | 1265 |
|
|
2024
Q1 | $1.54M | Sell |
52,785
-26,098
| -33% | -$802K | ﹤0.01% | 1397 |
|
|
2023
Q4 | $2.66M | Buy |
+78,883
| New | +$2.31M | 0.01% | 1184 |
|
|
2023
Q3 | – | Sell |
-58,964
| Closed | -$2.13M | – | 1124 |
|
|
2023
Q2 | $2.36M | Buy |
+58,964
| New | +$2.44M | 0.01% | 1136 |
|
|
2023
Q1 | – | Sell |
-96,707
| Closed | -$3.85M | – | 1223 |
|
|
2022
Q4 | $3.73M | Buy |
+96,707
| New | +$4.71M | 0.01% | 936 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1396 |
|
|
2022
Q1 | – | Sell |
-5,244
| Closed | -$316K | – | 2308 |
|
|
2021
Q4 | $316K | Buy |
+5,244
| New | +$289K | ﹤0.01% | 1658 |
|
|
2021
Q1 | – | Sell |
-75,647
| Closed | -$4.53M | – | 1962 |
|
|
2020
Q4 | $4.53M | Sell |
75,647
-122,990
| -62% | -$7.2M | 0.02% | 859 |
|
|
2020
Q3 | $11.9M | Sell |
198,637
-11,642
| -6% | -$676K | 0.05% | 412 |
|
|
2020
Q2 | $11M | Sell |
210,279
-29,604
| -12% | -$1.24M | 0.06% | 332 |
|
|
2020
Q1 | $8.04M | Buy |
239,883
+156,663
| +188% | +$6.51M | 0.05% | 354 |
|
|
2019
Q4 | $3.77M | Buy |
83,220
+53,774
| +183% | +$2.28M | 0.01% | 1099 |
|
|
2019
Q3 | $1.12M | Buy |
29,446
+11,446
| +64% | +$457K | ﹤0.01% | 1397 |
|
|
2019
Q2 | $783K | Buy |
+18,000
| New | +$764K | ﹤0.01% | 1583 |
|
|
2019
Q1 | – | Sell |
-14,217
| Closed | -$612K | – | 2041 |
|
|
2018
Q4 | $612K | Sell |
14,217
-31,600
| -69% | -$1.47M | ﹤0.01% | 1586 |
|
|
2018
Q3 | $2.25M | Buy |
45,817
+33,018
| +258% | +$1.43M | 0.01% | 1371 |
|
|
2018
Q2 | $410K | Buy |
+12,799
| New | +$442K | ﹤0.01% | 1853 |
|
Other funds holding PCRX
DPCM
